Hint mode is switched on Switch off

Eikon Therapeutics, ordinary share
EIKN, US2825641036

Add a stock to WL
Choose all Reset all
Eikon Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. It tracks and measures the real-time movement ...
Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. It tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Eikon Therapeutics, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    EIKN
  • Placement
    05.02.2026
  • Lock up period
    180
  • Number of papers
    21,177,600
  • Volume of raised funds
    381.2 mln USD
  • Placement share
    39.23%
  • Final placement price
    18 USD
  • Price change since placement date
    -48.83%
  • By capitalization
    971.72 mln USD

IFRS/US GAAP reports

2026
I q eng

Related Stock indices

Indicators

News

05/06/2026 Eikon Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
30/05/2026 Eikon Therapeutics: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
11/05/2026 Eikon Therapeutics: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
30/03/2026 Eikon Therapeutics: Results Of Operations And Financial Condition, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.